MARVIN BAULA: Open Payments
NPI 1104156819 · MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,732 in 318 payments from 14 companies in 2025. Trend: 2023 $3,558 · 2024 $4,381 · 2025 $5,732
Food & beverage: $5,728Education: $4
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 50 | $947 |
| Axsome Therapeutics, Inc. | 32 | $869 |
| Vanda Pharmaceuticals Inc. | 26 | $625 |
| Janssen Pharmaceuticals, Inc | 17 | $597 |
| Teva Pharmaceuticals USA, Inc. | 42 | $584 |
| Alkermes, Inc. | 29 | $518 |
| ABBVIE INC. | 36 | $470 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $455 |
| Lundbeck LLC | 28 | $322 |
| Otsuka America Pharmaceutical, Inc. | 15 | $196 |
Products named: COBENFY, Auvelity, INVEGA SUSTENNA, VRAYLAR, CAPLYTA, AUSTEDO XR, ARISTADA, HETLIOZ.
Industry payments across OH — which companies pay providers there.
